![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](dn2211contents.gif)
Acta Cryst. (2007). E63, o3686-o3687 [ doi:10.1107/S1600536807033259 ]
Abstract: The title compound, C22H21ClN2O2, obtained from the reaction of the phenazine of
-lapachone with trichloroisocyanuric acid, showed a minimum inhibitory concentration of 6.25 ng ml-1 in tuberculostatic assays against Mycobacterium tuberculosis and established a new structural type with potential interest in medicinal chemistry. The dihydropyran ring adopts a pure chair conformation, while the ring fused to it has a half-chair conformation. The two substituents, OMe and Cl, are in axial positions, due to anomeric effects towards the methoxy derivative.
Online 3 August 2007
Copyright © International Union of Crystallography
IUCr Webmaster